SCHEMBL6233069

SCHEMBL6233069

NN(C=O)Cc1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.50
AOC3 Q16853 1/20 0.49
TAAR1 Q96RJ0 2/20 0.47
IDO1 P14902 3/20 0.46
CYP3A4 P08684 2/20 0.46
AGXT P21549 2/20 0.46
TSHR P16473 1/20 0.45
RECQL P46063 1/20 0.45
PYCR1 P32322 1/20 0.45
CHRM2 P08172 2/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR3E A5X5Y0 3/20 0.43
HTR3B O95264 3/20 0.43
HTR3A P46098 3/20 0.43
HTR3D Q70Z44 3/20 0.43
HTR3C Q8WXA8 3/20 0.43
RIPK1 Q13546 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5547339 0.79 PYCR1 (0.53) PNMTAOC3TAAR1TSHRRECQL
SCHEMBL5542363 0.77 TAS2R14 (0.48) PNMTTAAR1TSHRRECQLPYCR1
SCHEMBL536198 0.77 AOC3 (0.52) AOC3TSHRKDM4E
SCHEMBL11746708 0.76 AOC3 (0.68) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL25840770 0.74 TSHR (0.65) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL20957066 0.74 TAS2R14 (0.51) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL4344662 0.73 PNMT (0.44) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL167780 0.72 PNMT (0.56) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL8290710 0.71 TAAR1 (0.66) PNMTAOC3TAAR1IDO1CYP3A4
SCHEMBL30798978 0.71 TAAR1 (0.66) PNMTAOC3TAAR1IDO1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1004582-B1 Pyridazino quinoline compounds ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
EP-0790996-B1 PYRIDAZINOQUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-03-27 EP disclosed
US-6232313-B1 TREATING STROKE OR EPILEPTIC CONVULSIONS ASSOCIATED WITH EXCESSIVE CALCIUM INFLUX IN THE BRAIN CAUSED BY EXCITATORY AMINO ACIDS ZENECA LIMITED (GB) 2001-05-15 US disclosed
EP-0724583-B1 PYRIDAZINO QUINOLINE COMPOUNDS ASTRAZENECA AB (SE) 2000-12-13 EP disclosed
EP-1004582-A2 Pyridazino quinoline compounds AstraZeneca UK Limited (GB) 2000-05-31 EP disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed